CAS: 1037624-75-1 - BGB 324
Formula:C30H34N8
InChI:InChI=1S/C30H34N8/c31-29-33-30(32-24-13-10-20-11-14-25(15-12-22(20)18-24)37-16-3-4-17-37)36-38(29)27-19-23-8-5-7-21-6-1-2-9-26(21)28(23)35-34-27/h1-2,6,9-10,13,18-19,25H,3-5,7-8,11-12,14-17H2,(H3,31,32,33,36)/t25-/m0/s1
InChI key:InChIKey=KXMZDGSRSGHMMK-VWLOTQADSA-N
SMILES:N1=NC=2C3=CC=CC=C3CCCC2C=C1N4N=C(N=C4N)NC5=CC=C6C(=C5)CCC(N7CCCC7)CC6
- Synonyms:
- BGB 324
- 1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7-(S)-pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulene-2-yl]-1H-1,2,4-triazole-3,5-diamine
- 1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl]-1H-1,2,4-triazole-3,5-diamine
- R 428
- 1H-1,2,4-Triazole-3,5-diamine, 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl]-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Bemcentinib REF: TM-T6269CAS: 1037624-75-1 | 97% - 99.8% | 40.00 €~926.00 € | Thu 12 Dec 24 | |
R428 REF: 7W-GW4897CAS: 1037624-75-1 | - - - | 619.00 €~2,741.00 € | Thu 12 Dec 24 | |
R428 REF: 3D-BR166805CAS: 1037624-75-1 | Min. 95% | To inquire | Mon 16 Dec 24 | |
R 428 REF: TR-R060020CAS: 1037624-75-1 | - - - | 94.00 €~1,098.00 € | Wed 15 Jan 25 | |
R428 REF: IN-DA008TJACAS: 1037624-75-1 | 98% | - - - | Discontinued product |
Bemcentinib
Ref: TM-T6269
1mg | 40.00 € | ||
2mg | 52.00 € | ||
5mg | 85.00 € | ||
10mg | 142.00 € | ||
25mg | 208.00 € | ||
50mg | 270.00 € | ||
100mg | 455.00 € | ||
200mg | 608.00 € | ||
500mg | 926.00 € |
Ref: 7W-GW4897
1mg | 619.00 € | ||
5mg | 1,498.00 € | ||
10mg | 2,741.00 € |
R428
Ref: 3D-BR166805
Undefined size | To inquire |
R 428
Controlled ProductRef: TR-R060020
1mg | 94.00 € | ||
10mg | 424.00 € | ||
50mg | 1,098.00 € |
Ref: IN-DA008TJA
1mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |